Mycophenolate Mofetil-d4 – 5 mg

Brand:
Cayman
CAS:
1132748-21-0
Storage:
-20
UN-No:
Non-Hazardous - /

Mycophenolate mofetil-d4 is intended for use as an internal standard for the quantification of mycophenolate mofetil (Item No. 13988) by GC- or LC-MS. Mycophenolate mofetil is a prodrug form of mycophenolic acid (Item No. 21716).{37581,37582,37583} In vivo, mycophenolate mofetil (12.5 mg/kg) increases duration of transplant motor activity in a rabbit model of retroperitoneal heterotopic heart transplantation.{37581} It eliminates formation of microbleeds and hemorrhages in the cerebrum of stroke-prone spontaneously hypertensive rats.{37582} Mycophenolate mofetil also lowers mean arterial pressure (MAP) and reduces urinary albumin excretion and glomerulosclerosis, markers of renal damage, in a mouse model of systemic lupus erythematosus (SLE).{37583}  

 

Available on backorder

SKU: 25281 - 5 mg Category:

Description

An internal standard for the quantification of mycophenolate mofetil by GC- or LC-MS


Formal name: (4E)-6-(1,3-dihydro-4-hydroxy-6-methoxy-7-methyl-3-oxo-5-isobenzofuranyl)-4-methyl-4-hexenoic acid, 2-(4-morpholinyl)ethyl-1,1,2,2-d4 ester

Synonyms:  MMF-d4

Molecular weight: 437.5

CAS: 1132748-21-0

Purity: ≥99% deuterated forms (d1-d4)

Formulation: A solid


Application|Mass Spectrometry||Product Type|Biochemicals|Analytical Standards||Product Type|Biochemicals|Isotopically Labeled Standards|Deuterium||Product Type|Biochemicals|Small Molecule Inhibitors|MMPs||Product Type|Biochemicals|Small Molecule Inhibitors|Nucleic Acid Turnover/Signaling||Research Area|Cardiovascular System|Cardiovascular Diseases|Hypertension||Research Area|Cardiovascular System|Cardiovascular Diseases|Stroke||Research Area|Cardiovascular System|Heart||Research Area|Cardiovascular System|Kidney & Renal Disease||Research Area|Immunology & Inflammation|Adaptive Immunity||Research Area|Immunology & Inflammation|Autoimmunity|Lupus